0001437749-17-009604.txt : 20170518
0001437749-17-009604.hdr.sgml : 20170518
20170518214209
ACCESSION NUMBER: 0001437749-17-009604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170516
FILED AS OF DATE: 20170518
DATE AS OF CHANGE: 20170518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXTERA SURGICAL INC
CENTRAL INDEX KEY: 0001178104
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 943287832
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 900 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-364-9975
MAIL ADDRESS:
STREET 1: 900 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: CARDICA INC
DATE OF NAME CHANGE: 20020719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nikolchev Julian
CENTRAL INDEX KEY: 0001655738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51772
FILM NUMBER: 17856305
MAIL ADDRESS:
STREET 1: 900 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-05-16
0001178104
DEXTERA SURGICAL INC
DXTR
0001655738
Nikolchev Julian
C/O DEXTERA SURGICAL INC.
900 SAGINAW DRIVE
REDWOOD CITY
CA
94063
1
President and CEO
Series B Convertible Preferred Stock
0.27
2017-05-16
4
P
0
15
1000
A
Common Stock
55560
15
D
Series 1 Convertible Preferred Stock
0.27
2017-05-16
4
P
0
55560
A
Common Stock
55560
55560
D
Series 2 Convertible Preferred Stock
0.27
2017-05-16
4
P
0
27780
A
Common Stock
27780
27780
D
Each share of Series B convertible preferred stock was sold with warrants to purchase up to 3,704 shares of common stock (referred to as "Series 1 warrants") and warrants to purchase up to 1,852 shares of common stock (referred to as "Series 2 warrants").
Subject to certain ownership limitations, each share of the Series B convertible preferred stock is convertible at any time at the option of the holder into 3,704 shares of common stock.
There is no expiration date.
Subject to certain ownership limitations, the warrants are immediately exercisable.
The warrant expires on the fifth anniversary of the date of issuance.
The warrant expires on the first anniversary of the date of issuance.
The reported securities are included in the price equal to $1,000 per share of the Series B convertible preferred stock purchased.
/s/ Robert Y. Newell IV For: Julian N. Nikolchev
2017-05-18